- Does rituximab really induce hepatitis C virus reactivation?
[作者:Ennishi, D; Yokoyama, M; Terui, Y; Takeuchi, K; Ikeda, K; Tanimoto, M; Hatake, K,期刊:Journal of clinical oncology, 页码:4695-4696 , 文章类型: Letter,,卷期:2008年26-28]
-
- Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma
[作者:Haller, DG; Rothenberg, ML; Wong, AO; Koralewski, PM; Miller, WH; Bodoky, G; Habboubi, N; Garay, C; Olivatto, LO,期刊:Journal of clinical oncology, 页码:4544-4550 , 文章类型: Article,,卷期:2008年26-28]
- PurposeTo determine whether irinotecan plus oxaliplatin (IROX) is superior to irinotecan alone in patients with metastatic colorectal cancer (CRC) previously treated with single-agent fluoropyrimidines.Patients and Metho...
- Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113
[作者:Ajani, JA; Winter, K; Komaki, R; Kelsen, DP; Minsky, BD; Liao, ZX; Bradley, J; Fromm, M; Hornback, D; Willett, CG,期刊:Journal of clinical oncology, 页码:4551-4556 , 文章类型: Article,,卷期:2008年26-28]
- PurposeTwo nonoperative approaches (one without fluorouracil) using induction chemotherapy and then definitive chemoradiotherapy developed at two centers were compared in patients with localized esophageal cancer (LEC). ...
- Association between hepatitis B virus and pancreatic cancer
[作者:Hassan, MM; Li, DH; El-Deeb, AS; Wolff, RA; Bondy, ML; Davila, M; Abbruzzese, JL,期刊:Journal of clinical oncology, 页码:4557-4562 , 文章类型: Article,,卷期:2008年26-28]
- PurposeHepatitis B virus (HBV) and hepatitis C virus (HCV) are considered to be hepatotropic and are a major cause of hepatocellular carcinoma. However, little is known about the role of HBV and HCV infection in other ma...
- Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
[作者:Attard, G; Reid, AHM; Yap, TA; Raynaud, F; Dowsett, M; Settatree, S; Barrett, M; Parker, C; Martins, V; Folkerd, E; Clark, J; Cooper, CS; Kaye, SB; Dearnaley, D; Lee, G; de Bono, JS,期刊:Journal of clinical oncology, 页码:4563-4571 , 文章类型: Article,,卷期:2008年26-28]
- PurposeStudies indicate that castration-resistant prostate cancer (CRPC) remains driven by ligand-dependent androgen receptor (AR) signaling. To evaluate this, a trial of abiraterone acetate-a potent, selective, small-mo...
- Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma
[作者:Hahn, OM; Yang, C; Medved, M; Karczmar, G; Kistner, E; Karrison, T; Manchen, E; Mitchell, M; Ratain, MJ; Stadler, WM,期刊:Journal of clinical oncology, 页码:4572-4578 , 文章类型: Article,,卷期:2008年26-28]
- PurposeSorafenib is an antiangiogenic agent with activity in renal cancer. We conducted a randomized trial to investigate dynamic contrast magnetic resonance imaging (DCE-MRI) as a pharmacodynamic biomarker.Patients and ...
- Availability and use of palliative care and end-of-life services for pediatric oncology patients
[作者:Johnston, DL; Nagel, K; Friedman, DL; Meza, JL; Hurwitz, CA; Friebert, S,期刊:Journal of clinical oncology, 页码:4646-4650 , 文章类型: Article,,卷期:2008年26-28]
- PurposePalliative care prevents or relieves the symptoms caused by life-threatening medical conditions. Previous surveys have shown both underuse and lack of availability of these services for children with cancer throug...
- Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma
[作者:Marcus, R; Imrie, K; Solal-Celigny, P; Catalano, JV; Dmoszynska, A; Raposo, JC; Offner, FC; Gomez-Codina, J; Belch, A; Cunningham, D; Wassner-Fritsch, E; Stein, G,期刊:Journal of clinical oncology, 页码:4579-4586 , 文章类型: Article,,卷期:2008年26-28]
- PurposeTo compare the long-term outcome of patients with previously untreated follicular lymphoma (FL) needing therapy, after treatment with cyclophosphamide, vincristine and prednisone (CVP) versus CVP plus rituximab (R...
- Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer
[作者:Espie, CA; Fleming, L; Cassidy, J; Samuel, L; Taylor, LM; White, CA; Douglas, NJ; Engleman, HM; Kelly, HL; Paul, J,期刊:Journal of clinical oncology, 页码:4651-4658 , 文章类型: Article,,卷期:2008年26-28]
- PurposePersistent insomnia is a common complaint in cancer survivors, but is seldom satisfactorily addressed. The adaptation to cancer care of a validated, cost-effective intervention may offer a practicable solution. Th...
- Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
[作者:Fu, K; Weisenburger, DD; Choi, WWL; Perry, KD; Smith, LM; Shi, XL; Hans, CP; Greiner, TC; Bierman, PJ; Bociek, RG; Armitage, JO; Chan, WC; Vose, JM,期刊:Journal of clinical oncology, 页码:4587-4594 , 文章类型: Article,,卷期:2008年26-28]
- PurposeDiffuse large B-cell lymphoma (DLBCL) includes at least two prognostically important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell -like [ABC] DLBCL), which initially were characterized by g...
- Phase II study of imatinib in patients with recurrent gliomas of various histologies: A European organisation for research and treatment of cancer brain tumor group study
[作者:Raymond, E; Brandes, AA; Dittrich, C; Fumoleau, P; Coudert, B; Clement, PMJ; Frenay, M; Rampling, R; Stupp, R; Kros, JM; Heinrich, MC; Gorlia, T; Lacombe, D; van den Bent, MJ,期刊:Journal of clinical oncology, 页码:4659-4665 , 文章类型: Article,,卷期:2008年26-28]
- PurposeTo evaluate the safety and the efficacy of imatinib in recurrent malignant gliomas.Patients and MethodsThis was a single-arm, phase II study. Eligible patients had recurrent glioma after prior radiotherapy with an...
|